Eli Lilly (NYSE:LLY) today announced executive leadership changes as it creates neuroscience and immunology business units.
Indianapolis-based Eli Lilly split its bio-medicines segment into Lilly Neuroscience and Lilly Immunology in the organizational shift, to be made effective Sep. 5, with Anne White set to lead the neuroscience unit and Patrik Jonsson set to head up the immunology arm.
Get the full story at our sister site, Drug Delivery Business News.